358 related articles for article (PubMed ID: 15064337)
41. Intraarterial catheter-directed thrombolysis: urokinase versus tissue plasminogen activator.
Cinà CS; Goh RH; Chan J; Kenny B; Evans G; Rawlinson J; Gill G
Ann Vasc Surg; 1999 Nov; 13(6):571-5. PubMed ID: 10541608
[TBL] [Abstract][Full Text] [Related]
42. Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency.
Sillesen H; Just S; Jørgensen M; Baekgaard N
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):556-62. PubMed ID: 16125983
[TBL] [Abstract][Full Text] [Related]
43. A pilot study of pro-urokinase in the treatment of deep vein thrombosis.
Moia M; Mannucci PM; Pini M; Prandoni P; Gurewich V
Thromb Haemost; 1994 Sep; 72(3):430-3. PubMed ID: 7531876
[TBL] [Abstract][Full Text] [Related]
44. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study.
Drescher P; Crain MR; Rilling WS
J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692
[TBL] [Abstract][Full Text] [Related]
45. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
Collen D; Van de Werf F
Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
[TBL] [Abstract][Full Text] [Related]
46. Short- and long-term results after thrombolytic treatment of deep venous thrombosis.
Schweizer J; Kirch W; Koch R; Elix H; Hellner G; Forkmann L; Graf A
J Am Coll Cardiol; 2000 Oct; 36(4):1336-43. PubMed ID: 11028492
[TBL] [Abstract][Full Text] [Related]
47. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial.
Ouriel K; Castaneda F; McNamara T; Swischuk J; Tepe G; Smith JJ; Clark J; Duda S
J Vasc Interv Radiol; 2004 Mar; 15(3):229-38. PubMed ID: 15028807
[TBL] [Abstract][Full Text] [Related]
48. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.
Gurbel PA; Serebruany VL; Shustov AR; Bahr RD; Carpo C; Ohman EM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1466-73. PubMed ID: 9626821
[TBL] [Abstract][Full Text] [Related]
49. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895
[TBL] [Abstract][Full Text] [Related]
50. Pulse-spray thrombolysis with reteplase: optimization and comparison with tPA in a rabbit model.
Bookstein JJ; Bookstein FL
J Vasc Interv Radiol; 2001 Nov; 12(11):1319-24. PubMed ID: 11698632
[TBL] [Abstract][Full Text] [Related]
51. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction.
Bode C; Schuler G; Nordt T; Schönermark S; Baumann H; Richardt G; Dietz R; Gurewich V; Kübler W
Circulation; 1990 Mar; 81(3):907-13. PubMed ID: 2106403
[TBL] [Abstract][Full Text] [Related]
52. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
Viegas LD; Stolz E; Canhão P; Ferro JM
Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
[TBL] [Abstract][Full Text] [Related]
53. [Catheter directed thrombolysis for early left lower extremity deep venous thrombosis without vena cava filters protection].
Xiao L; Gong KM; Wang KH; Lü YJ; Chen ZS; Ouyang YM; Ling P; Long YX; Li LH
Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):15-8. PubMed ID: 22490283
[TBL] [Abstract][Full Text] [Related]
54. Deep vein thrombosis: a mininvasive locoregional thrombolytic treatment.
Ippolito E; Molinari A; Romagnoli S; Belcaro G; Cesarone MR; Urgnani F; Bonadeo P
Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):63-70. PubMed ID: 19597411
[TBL] [Abstract][Full Text] [Related]
55. Comparison of streptokinase and urokinase in local thrombolysis of peripheral arterial occlusions for lower limb salvage.
Dubé M; Soulez G; Thérasse E; Cartier P; Blair JF; Roy P; Robillard P; Bruneau L; Van Nguyen P; Cusson JR
J Vasc Interv Radiol; 1996; 7(4):587-93. PubMed ID: 8855542
[TBL] [Abstract][Full Text] [Related]
56. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.
Noble S; McTavish D
Drugs; 1996 Oct; 52(4):589-605. PubMed ID: 8891469
[TBL] [Abstract][Full Text] [Related]
57. Failure of thrombolytic therapy in four children with extensive thromboses.
Ryan CA; Andrew M
Am J Dis Child; 1992 Feb; 146(2):187-93. PubMed ID: 1733148
[TBL] [Abstract][Full Text] [Related]
58. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
59. Thrombolysis with reteplase for recurrent mechanical heartvalve thrombosis.
Akhtar N; Khan YJ; Ahmed W
J Pak Med Assoc; 2011 Feb; 61(2):189-92. PubMed ID: 21375177
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of low-cost alternative urokinase in acute ischemic stroke: A systematic review and meta-analysis.
Kharel S; Nepal G; Joshi PR; Yadav JK; Shrestha TM
J Clin Neurosci; 2022 Dec; 106():103-109. PubMed ID: 36274296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
